Publication | Open Access

Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms

Survival OutcomesRadiation TherapyRobust Prognostic NomogramsMedicineBronchial Neoplasm5-Year ProgressionOncologyRadiation OncologyLung CancerRadiologyHealth Sciences